Changing FLT3 Inhibition Landscape in AML @UCSFCancer

Changing FLT3 Inhibition Landscape in AML @UCSFCancer

obr

3 months
1 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Catherine Smith, MD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, @UCSFCancer offers her overall impression on the changing FLT3 inhibition landscape in acute myeloid leukemia (AML).
Up Next Autoplay